NCT07162948 ICU-Recover Box 2.0, Smart Technology for Home Monitoring of ICU Patients
| NCT ID | NCT07162948 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Leiden University Medical Center |
| Condition | ICU Acquired Weakness |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-07-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Smart technology could improve quality of care in patients who have been admitted to the ICU and have been discharged from ICU and hospital, by early diagnosis of complications and early (ambulatory) treatment. With the ICU-Recover Box and its smart technology the investigators see new opportunities to improve patient health and to recognize early if escalation of medical care is needed. The primary objective of the pilot study is to assess the feasibility of the use of smart technology by persons that have been discharged from the ICU in the twelve months following ICU discharge.
Eligibility Criteria
Inclusion Criteria: * Patient has been admitted to the ICU of the LUMC for \> 24 hours. * Patient has received mechanical ventilation. * Patient masters the English or Dutch language. * Patient is able to use smart technology at home. (i.e. Wi-Fi available, sufficient comprehension of smart technology). * Patient can be contacted and informed about the ICU-Recover box on one of the clinical wards of the LUMC. * Patient is discharged from a ward within the LUMC to home or an extra-hospital facility. Exclusion Criteria: * Patient is \< 18 years old. * Patient is pregnant. * Patient breastfeeds during the course of the study. * Patient is discharged for palliative care. * Patient is considered an incapacitated adult. * Patient is unwilling to sign the informed consent form. * Patient is discharged to another hospital.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07162948 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ICU Acquired Weakness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07162948 currently recruiting?
Yes, NCT07162948 is actively recruiting participants. Contact the research team at marbous@lumc.nl for enrollment information.
Where is the NCT07162948 trial being conducted?
This trial is being conducted at Leiden, Netherlands.
Who is sponsoring the NCT07162948 clinical trial?
NCT07162948 is sponsored by Leiden University Medical Center. The trial plans to enroll 50 participants.